Abstract
While chemotherapy can cure several tumours even in advanced stages, like testicular cancer, several cancers of childhood and some haematological malignancies, and can prolonge survival in a number of other malignancies, relapse is often inevitable in the majority of patients due to the occurrence of drug resistance to a broad variety of antineoplastic agents [1]. Drug resistance can be intrinsic or acquired. The former refers to tumours which are initially unresponsive to chemotherapy. Acquired drug resistance develops in a responsive tumour during treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Pinedo HM, Longo D, Chabner B, eds (1991) Cancer Chemotherapy and Biological Response Modifiers, Annual 12. Elsevier Science Publishers, Amsterdam
De Vita VT Jr (1990) The problem of resistance; keynote address. In: Mihich E (ed) Drug resistance: mechanisms and reversal. John Libbey CIC, Rome, pp 7–27
Borst P (1991) Genetic mechanisms of drug resistance. A review. Reviews in Oncology 4 (in Acta Oncologica 30): 87105
Allegra CJ, Grem, JL, Chu E, Johnston P, Chao Yeh G, Chabner BA (1990) Antimetabolites. In: Pinedo HM (ed) Cancer Chemotherapy. The EORTC Cancer Chemotherapy Annual n° 12
Peters GJ, Van der Wilt, CL, Van Groeningen CJ et al (1990) Development of 5-Fluorouracil-Leucovorin combinations. In: Pinedo HM, Rustum YM (eds) Leucovorin modulation of fluoropyrimidines: a new frontier in cancer chemotherapy. International Congress and Symposium Series, n° 158. Royal Society of Medicine Services Ltd., London, pp 21–35
Pinedo HM, Peters GJ (1988) Fluorouracil: Biochemistry and pharmacology. J Clin Oncol 6: 1653–1664
Van Kalken CK, Pinedo HM, Giaccone G (1991) Multidrug resistance from the clinical point of view. Eur J Cancer 27: 1481–1486
Miller TP, Grogan TM, Dalton WS et al (1991) P-Glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose Verapamil. J Clin Oncol 9: 17–24
Giaccone G, Gazdar AF, Beck H et al (1992) Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res 52: 1666–1674
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag France
About this paper
Cite this paper
Linn, S.C., Giaccone, G., Pinedo, H.M. (1994). Clinical relevance of drug resistance: Where do we stand now and where are we going to ?. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_5
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0765-2_5
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0767-6
Online ISBN: 978-2-8178-0765-2
eBook Packages: Springer Book Archive